Joan Connolly
Equibles does not estimate personal net worth.
Get an email with a short summary when enGene Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ENGN alertsAbout Joan Connolly
Joan Connolly is recorded as CTO at enGene Therapeutics Inc. (ENGN). The newest filing on record that lists Joan Connolly as CTO at enGene Therapeutics Inc. (ENGN) is dated May 8, 2026. enGene Therapeutics Inc. reported in an 8-K filed October 21, 2024 that Joan Connolly was appointed Chief Technology Officer (CTO). enGene Therapeutics Inc. reported in an 8-K filed October 21, 2024 that Joan Connolly was appointed Chief Technology Officer, effective October 21, 2024. enGene Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at enGene Therapeutics Inc. includes Ron Cooper (CEO and Board Member), Ronald H. W. Cooper (CEO and Board Member), Ronald H.W. Cooper (CEO and Board Member) and 7 others.
“enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral lead investigational product detalimogene voraplasmid (also known as detalimogene, and previously EG-70) is in an ongoing pivotal study in patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis), today announced the appointment of Joan Connolly as Chief Technology Officer (CTO) and member of the corporate leadership team.”
“In connection with Dr. Cheung’s transition to the role of Chief Scientific Officer, the Company announced the appointment of Joan Connolly as Chief Technology Officer, effective as of October 21, 2024.”
Affiliation history
-
Current
Start not stated–present
Last confirmed May 8, 2026
Company network
Leadership on record at enGene Therapeutics Inc.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Dr. William Grossman Board Member
- Gerald Brunk Board Member